- Home
- Publications
- Publication Search
- Publication Details
Title
Discovering Anti-Cancer Drugs via Computational Methods
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-20
DOI
10.3389/fphar.2020.00733
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug Discovery Researches on Modulators of Lysine-Modifying Enzymes Based on Strategic Chemistry Approaches
- (2020) Yukihiro Itoh CHEMICAL & PHARMACEUTICAL BULLETIN
- Zanubrutinib: First Approval
- (2020) Yahiya Y. Syed DRUGS
- Enhancing the Signaling of GPCRs via Orthosteric Ions
- (2020) H. C. Stephen Chan et al. ACS Central Science
- Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib
- (2019) Yudong Su et al. Targeted Oncology
- Structure of the IFNγ receptor complex guides design of biased agonists
- (2019) Juan L. Mendoza et al. NATURE
- Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2019) Catherine Owens Johnson et al. LANCET NEUROLOGY
- Gilteritinib: First Global Approval
- (2019) Sohita Dhillon DRUGS
- Adjuvant therapeutic approaches of HER2-positive breast cancer with a focus on neratinib maleate
- (2019) N. Kotecki et al. Expert Review of Anticancer Therapy
- Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
- (2019) Xin Yang et al. CHEMICAL REVIEWS
- Alpelisib: First Global Approval
- (2019) Anthony Markham DRUGS
- Erdafitinib: First Global Approval
- (2019) Anthony Markham DRUGS
- Entrectinib: First Global Approval
- (2019) Zaina T. Al-Salama et al. DRUGS
- A Glycoconjugated SIRT2 Inhibitor with Aqueous Solubility Allows Structure-Based Design of SIRT2 Inhibitors
- (2019) Jun Young Hong et al. ACS Chemical Biology
- Apalutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
- (2019) Zaina T. Al-Salama DRUGS
- Selinexor: First Global Approval
- (2019) Yahiya Y. Syed DRUGS
- Crystal structures and antitumor activity evaluation against gastric carcinoma of two novel coordination polymers
- (2019) Bin Yan et al. MAIN GROUP CHEMISTRY
- Deep learning enables rapid identification of potent DDR1 kinase inhibitors
- (2019) Alex Zhavoronkov et al. NATURE BIOTECHNOLOGY
- Advancing Drug Discovery via Artificial Intelligence
- (2019) H.C. Stephen Chan et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Darolutamide: First Approval
- (2019) Anthony Markham et al. DRUGS
- In silico design, synthesis and activity of potential drug-like chrysin scaffold-derived selective EGFR inhibitors as anticancer agents
- (2019) Sudhan Debnath et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- Structure-Based Identification and Design of Angiotensin Converting Enzyme-Inhibitory Peptides from Whey Proteins
- (2019) Anna Rita Tondo et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non–Small Cell Lung Cancer
- (2018) Enriqueta Felip et al. Journal of Thoracic Oncology
- Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial
- (2018) Michael B Atkins et al. LANCET ONCOLOGY
- Cemiplimab effective in cutaneous SCC
- (2018) Peter Sidaway Nature Reviews Clinical Oncology
- PARP Inhibitors in Ovarian Cancer
- (2018) Gloria Mittica et al. Recent Patents on Anti-Cancer Drug Discovery
- Machine intelligence decrypts β-lapachone as an allosteric 5-lipoxygenase inhibitor
- (2018) Tiago Rodrigues et al. Chemical Science
- Large-scale comparison of machine learning methods for drug target prediction on ChEMBL
- (2018) Andreas Mayr et al. Chemical Science
- Exploring a new ligand binding site of G protein-coupled receptors
- (2018) H.C. Stephen Chan et al. Chemical Science
- Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
- (2018) Rafael Gómez-Bombarelli et al. ACS Central Science
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Development of Pharmacophore Modeling: Generation and Recent Applications in Drug Discovery
- (2018) Xin Lu et al. CURRENT PHARMACEUTICAL DESIGN
- Encorafenib and Binimetinib: First Global Approvals
- (2018) Matt Shirley DRUGS
- Ivosidenib: First Global Approval
- (2018) Sohita Dhillon DRUGS
- Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview
- (2018) Veronica Salmaso et al. Frontiers in Pharmacology
- Activity of the Hsp90 inhibitor Luminespib Among Non-Small Cell Lung Cancers Harboring EGFR Exon 20 Insertions
- (2018) Z Piotrowska et al. ANNALS OF ONCOLOGY
- Evaluation of the effects of formulation, food, or a proton-pump inhibitor on the pharmacokinetics of glasdegib (PF-04449913) in healthy volunteers: a randomized phase I study
- (2018) Naveed Shaik et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Duvelisib: First Global Approval
- (2018) Hannah A. Blair DRUGS
- Molecular mechanism and targeted therapy of Hsp90 involved in lung cancer: New discoveries and developments (Review)
- (2017) Biaoxue Rong et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Trends in GPCR drug discovery: new agents, targets and indications
- (2017) Alexander S. Hauser et al. NATURE REVIEWS DRUG DISCOVERY
- Drugging Undruggable Molecular Cancer Targets
- (2016) John S. Lazo et al. Annual Review of Pharmacology and Toxicology
- Deciphering the Complexity of Ligand–Protein Recognition Pathways Using Supervised Molecular Dynamics (SuMD) Simulations
- (2016) Alberto Cuzzolin et al. Journal of Chemical Information and Modeling
- Improving quantitative structure–activity relationship models using Artificial Neural Networks trained with dropout
- (2016) Jeffrey Mendenhall et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Allosteric coupling from G protein to the agonist-binding pocket in GPCRs
- (2016) Brian T. DeVree et al. NATURE
- Understanding allosteric interactions in G protein-coupled receptors using Supervised Molecular Dynamics: A prototype study analysing the human A3 adenosine receptor positive allosteric modulator LUF6000
- (2015) Giuseppe Deganutti et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Drug–target interaction prediction: databases, web servers and computational models
- (2015) Xing Chen et al. BRIEFINGS IN BIOINFORMATICS
- Improvements, trends, and new ideas in molecular docking: 2012-2013 in review
- (2015) Elizabeth Yuriev et al. JOURNAL OF MOLECULAR RECOGNITION
- Molecular Docking and Structure-Based Drug Design Strategies
- (2015) Leonardo Ferreira et al. MOLECULES
- Universal allosteric mechanism for Gα activation by GPCRs
- (2015) Tilman Flock et al. NATURE
- Targeting Conformational Plasticity of Protein Kinases
- (2014) Michael Tong et al. ACS Chemical Biology
- GPCR structures in drug design, emerging opportunities with new structures
- (2014) Christofer S. Tautermann BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Supervised Molecular Dynamics (SuMD) as a Helpful Tool To Depict GPCR–Ligand Recognition Pathway in a Nanosecond Time Scale
- (2014) Davide Sabbadin et al. Journal of Chemical Information and Modeling
- Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus
- (2014) D. Reker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Methods and Applications of Structure Based Pharmacophores in Drug Discovery
- (2013) Somayeh Pirhadi et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Inhibition of HSP90 molecular chaperones: moving into the clinic
- (2013) Rocio Garcia-Carbonero et al. LANCET ONCOLOGY
- Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement
- (2013) Richard Schwab et al. LUNG CANCER
- Glossary of terms used in medicinal chemistry. Part II (IUPAC Recommendations 2013)
- (2013) Derek R. Buckle et al. PURE AND APPLIED CHEMISTRY
- Anti-VEGF Therapies in the Clinic
- (2013) K. L. Meadows et al. Cold Spring Harbor Perspectives in Medicine
- Drug target prediction using adverse event report systems: a pharmacogenomic approach
- (2012) M. Takarabe et al. BIOINFORMATICS
- Structure Based Drug Design of Angiotensin-I Converting Enzyme Inhibitors
- (2012) C. S. Anthony et al. CURRENT MEDICINAL CHEMISTRY
- Recommendation as link prediction in bipartite graphs: A graph kernel-based machine learning approach
- (2012) Xin Li et al. DECISION SUPPORT SYSTEMS
- Performance Evaluation of 2D Fingerprint and 3D Shape Similarity Methods in Virtual Screening
- (2012) Guoping Hu et al. Journal of Chemical Information and Modeling
- Drug–target interaction prediction by random walk on the heterogeneous network
- (2012) Xing Chen et al. Molecular BioSystems
- METAmplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
- (2011) Jochen K. Lennerz et al. JOURNAL OF CLINICAL ONCOLOGY
- Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
- (2011) J. Jean Cui et al. JOURNAL OF MEDICINAL CHEMISTRY
- Allosteric Modulation of Family C G-Protein-Coupled Receptors: from Molecular Insights to Therapeutic Perspectives
- (2011) S. Urwyler PHARMACOLOGICAL REVIEWS
- Biochemical network-based drug-target prediction
- (2010) Edda Klipp et al. CURRENT OPINION IN BIOTECHNOLOGY
- Pharmacophore modeling and applications in drug discovery: challenges and recent advances
- (2010) Sheng-Yong Yang DRUG DISCOVERY TODAY
- Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
- (2010) James E. Butrynski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Scoring functions and their evaluation methods for protein–ligand docking: recent advances and future directions
- (2010) Sheng-You Huang et al. PHYSICAL CHEMISTRY CHEMICAL PHYSICS
- Troubleshooting computational methods in drug discovery
- (2010) Sandhya Kortagere et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Generation of Ligand-Based Pharmacophore Model and Virtual Screening for Identification of Novel Tubulin Inhibitors with Potent Anticancer Activity
- (2009) Yi-Kun Chiang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Prediction of drug-target interaction networks from the integration of chemical and genomic spaces
- (2008) Y. Yamanishi et al. BIOINFORMATICS
- Molecular Docking Algorithms
- (2008) Raquel Dias et al. CURRENT DRUG TARGETS
- EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy
- (2008) Francesco Giammarile et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Targeting the c-MET signaling pathway for cancer therapy
- (2008) Xiangdong Liu et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Network pharmacology: the next paradigm in drug discovery
- (2008) Andrew L Hopkins Nature Chemical Biology
- Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
- (2008) P. Jeffrey Conn et al. NATURE REVIEWS DRUG DISCOVERY
- Drug Target Identification Using Side-Effect Similarity
- (2008) M. Campillos et al. SCIENCE
- Computer-aided drug discovery and development (CADDD): In silico-chemico-biological approach
- (2006) I.M. Kapetanovic CHEMICO-BIOLOGICAL INTERACTIONS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started